Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05887609
Title An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.